04/25/2026
According to recent research, elevated lipoprotein (a) levels are associated with residual cardiovascular risk.
New data analyzing more than 20,000 patients from three major NIH studies show that elevated Lipoprotein(a) [Lp(a)] is associated with residual cardiovascular risk and warrants aggressive risk reduction.